A college student never learned the cause of intense pain that drove her to an ER, but her bill totaled $18,735.93. She and her mom, a nurse practitioner, were outraged after dissecting the charges.
Scientists successfully treated a rare disease with the experimental gene-editing technique. It could open the door to new ways of treating more common disorders in the future.
The practice of housing children who are in psychiatric crisis in local ERs — often for days, while they await appropriate in-patient treatment — has become even more prevalent during the pandemic.
More contagious than other variants, and maybe more likely to cause severe disease, Delta is spreading so fast in the U.S. it could cause another surge this summer or fall, according to new research.
An NPR correspondent living with incurable cancer says 7% is no solution. That's one estimate of how much — or how little — breast cancer research funding goes toward metastatic disease.
Health officials are investigating reports of mostly mild, temporary and treatable heart inflammation that may or may not be causally linked to vaccination with an mRNA vaccine against COVID-19.
Experts now say the procedure is the most effective treatment for severe childhood obesity, which affects a growing number of kids. But stigma and insurers often stand in the way.
The system is designed to provide early warning of what might or might not be actual side effects. But anti-vaccine groups are bending the data to their own ends.
A plaque-busting Alzheimer's drug called Aduhelm has yet to prove it can preserve memory and thinking. Even so, its approval by the Food and Drug Administration is making some patients opitimistic.
The COVID vaccines haven't proved very effective for people living with organ transplants. But getting a third dose of the mRNA vaccines gave a big bump in antibody levels in a new study.
A surge in pet adoptions has increased demand for dogs imported from around the world. Most are fine, but federal officials turned up 450 dogs in 2020 with false records — 50% more than in 2019.
In a large-scale study, Novavax said its vaccine was completely effective against the original coronavirus strain and also effective against some variants. It works differently than other vaccines.
After a stroke, people often lose dexterity in one hand. Now, the Food and Drug Administration has authorized a device that can restore function by encouraging the brain to rewire.
In his resignation letter, Dr. Aaron Kesselheim calls it "probably the worst drug approval decision in recent U.S. history." An FDA official says the agency found the benefits outweighed the risks.
